Michael Deamer represents clients in all facets of commercial litigation. Prior to joining Keker, Van Nest & Peters, Michael served as a law clerk to Judge William Alsup of the U.S. District Court for the Northern District of California and as a litigation associate for an Am Law Top 25 law firm.
Michael earned a J.D. from the University of California, Berkeley, School of Law and B.A. in Rhetoric and English from the University of California, Berkeley. While in law school, he served as a legal intern for the Electronic Frontier Foundation and the Executive Office of the Attorney General for the California Department of Justice. Before law school, Michael worked as a legal assistant for a global technology company, where he processed legal demands for content removal.
We represented Sutter Health in defeating a qui tam action alleging violation of California's Insurance Frauds Prevention Act in a case related to charges for health care services. Following a seven-week bench trial, we obtained a complete victory. The judge ruled that there was no fraud, that Sutter charged for recovery room care that was “medically ordered, appropriate, and supervised,” and that Sutter’s charges were consistent with standard industry billing practices.
We defended Dexcom in the District of Delaware where Abbott asserted a dozen patents targeting Dexcom’s G6 continuous glucose monitoring technology. The Keker team narrowed the case to four patents prior to trial, including by invalidating an Abbott patent at summary judgment, and excluded Abbott’s expert testimony regarding reasonable royalty damages. Following a two-week trial, the jury invalidated another Abbott patent and found two were not infringed. The Court also declined to let the Jury consider damages on the remaining patent, cementing a defense victory for the Keker trial team.
A California state judge has handed Sutter Health a win following a weeks-long bench trial last year over a whistleblower's claims that the nonprofit hospital network violated the state's insurance fraud prevention statutes. Read more
Law360 has reported that a Delaware federal jury has cleared Dexcom, represented by Keker, Van Nest & Peters, of infringing two glucose monitor patents owned by an Abbott Laboratories unit, while finding infringement of one that was not willful. It hung on a fourth. The trial was overseen by Third Circuit Judge Kent A. Jordan in the U.S. District of Delaware, who decided a second trial will be held to determine any damages. Read more
“DC Comics v. Towle: Protecting Fictional Characters Through Stewardship,” 32 Berkeley Technology Law Journal 437 (2017)